Algeta, Sanofi deal

Algeta and Sanofi's Genzyme Corp. subsidiary extended by one year to April 2013 a 2011 deal to use Algeta's Thorium platform to create a targeted thorium conjugate (TTC) of thorium-227, an alpha-par...